MENU

Michael Jay Styler, MD

Dr. Michael Styler

Clinical Locations

Primary Location

Fox Chase–Temple University Hospital Bone Marrow Transplant Program
Jeanes Hospital
Patient Care Center, Fifth Floor
7600 Central Avenue
Philadelphia, PA 19111

About

Specialties

Treatment Focus

Leukemia, Myelodysplasia, Myeloproliferative Neoplasms, Multiple Myeloma, Aplastic Anemia, Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma.

Treatment Philosophy

I am a hematologist/oncologist specializing in the treatment of patients with hematologic malignancies (blood-related cancers). This is an exciting time in cancer treatment, with many new, highly effective and increasingly less toxic therapies being discovered and approved every day. I am delighted to have joined the faculty of Fox Chase Cancer Center in the Bone Marrow Transplant program, which is at the forefront of some of the most promising and effective treatments for patients with hematologic malignancies. I believe in partnering with my patients to jointly decide the best course of therapy to help them achieve their most important goals, while both maximizing their chances for survival and optimizing their quality of life.

Education and Training

Educational Background

  • Fellowship, Hematology/Oncology, Hahnemann University Hospital, Philadelphia, PA, 1988-91
  • Intern, Internal Medicine, Hahnemann University Hospital, Philadelphia, PA, 1984-85
  • MD, Medical College of Wisconsin, Milwaukee, WI, 1984

Certifications

  • Diplomat of American Board of Internal Medicine
    • Subspecialty of Hematology
    • Subspecialty of Medical Oncology

Memberships

  • American Society for Blood and Bone Marrow Transplant
  • American Society of Clinical Oncology
  • American Society of Hematology
Research Profile

Research Interests

Hematopoietic stem cell transplantation and cellular therapies for patients with multiple myeloma, lymphoma, leukemia, myelodysplasia, myeloproliferative neoplasms and sickle cell anemia.

Publications

Selected Publications

Jeurkar, C., Yeung, H., Pompa, T., Styler, M. Comparing risk models guiding growth factor use in chemotherapy. Journal of Community and Supportive Oncology Care. 2018;16(6):e256-e259.

Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Žák P, Craig MD, Papanicolaou GA, Velez JD, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao Y, Chan ISF, Kaplan SS, Parrino J, Lee I, Popmihajlov Z, Annunziato PW, Arvin A; V212 Protocol 001 Trial Team. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018 May 26;391(10135):2116-2127. doi: 10.1016/S0140-6736(18)30631-7. Epub 2018 May 24 PubMed

Khalili M, Morano WF, Marconcini L, Shaikh MF, Gleeson EM, Styler M, Zebrower M, Bowne WB. Multidisciplinary strategies in bloodless medicine and surgery for patients undergoing pancreatectomy. J Surg Res. 2018 Sep; 229:208-215. doi: 10.1016/j.jss.2018.04.009. Epub 2018 May 1. PubMed

Platoff RM, Morano WF, Marconcini L, DeLeo N, Mapow BL, Styler M, Bowne WB. Recurrent Gastrointestinal Stromal Tumors in the Imatinib Mesylate Era: Treatment Strategies for an Incurable Disease. Case Rep Oncol Med. 2017; 2017:8349090. doi: 10.1155/2017/8349090. Epub 2017 Nov 30. PubMed

Solitary skeletal muscle metastasis as first site of recurrence of cervical cancer - a case report.

Yeung, HM, Jeurkar, C, Pompa, T and Styler, M. Small Cell Cancer of the Genitourinary Tract: A Case Report and Review of the Literature. Case Rep Oncol 2017; Jun 9; 10:489-492. doi: 10.1159/000477435. eCollection 2017 May-Aug. PubMed

Chojecky, A., Gharibo, M. and Styler, M. Hyperammonemia, an under-recognized complication and adverse prognostic marker in Multiple Myeloma. Cell death in therapy. PSJD

Jaworski JM, Swami VK, Heintzelman RC, Cusack CA, Chung CL, Peck J, Fanelli M, Styler M, Rizk S, Hou JS. Blastic Plasmacytoid dendritic cell neoplasm with absolute monocytosis at presentation. Pathology and Laboratory Medicine International. 12 February 2015 Volume 2015:7, 7—10.

Dezern AE, Styler MJ, Drachman DB, Hummers LK, Jones RJ, Brodsky RA..  Repeated Treatment for Severe Autoimmune Diseases with High Dose Cyclophosphamide. Am J Blood Res. 2013; 3(1): 84–90.

Vatanparast, R., Lantz, S., Ward, K., Crilley, P., Styler, M. Evaluation of a Pre-test Scoring System (4Ts) for the Diagnosis of HIT in a University Hospital Setting. Postgrad Med. 2012 Nov;124(6):36-42. PubMed

R.A. Ener, A. Georgakis, J. Jin, S. Kunapuli, D.L. Topolsky, M.J. Styler: The Effect Of Iomeprol On Platelet Aggregation And Potential Risk Of Thrombogenecity. The Internet Journal of Hematology. 2012 Volume 8 Number 1. DOI: 10.5580/2c44.

Bachegowda LS, Nagaraj G, Grivas PD, Chen L, Choi E, Styler M Two "childhood" malignancies in an elderly individual: a case report and discussion. Med Oncol. 2009 Sep 4.

Saloura V, Grivas PD, Mapow D, Kazmi K, Ward K, Styler M. Intracerebral progression of Hodgkin lymphoma in a man with HIV. PubMed

Subramanya D, Grivas PD, Styler M. Appendiceal carcinoma: a diagnostic and therapeutic challenge. Postgrad Med. 2008 Nov; 120 (4): 95-100. PubMed

Additional Publications

MyNCBI

Connect with Fox Chase